Delivery Order SPE2DB22D1106-SPE2DB25FFBU6
Award Date 8/6/25
Potential Completion Date 8/7/25
Potential Value $7.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,736.64 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MULTAQ (dronedarone) is an antiarrhythmic medication used to treat atrial fibrillation, reflecting the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) under a firm fixed-price contract valued at $29,062.23. The delivery order, issued on September 12, 2025, carries an ultimate completion date of September 15, 2025, and represents a non-set-aside competitive award. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters location. This delivery order is a...
- The Defense Logistics Agency awarded a $11,457.08 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on September 9, 2025, with a completion date of September 10, 2025. This competitive award with firm fixed pricing represents a pharmaceutical supply delivery under a child contract arrangement. Multaq (dronedarone) is an antiarrhythmic medication used to treat atrial fibrillation, reflecting the company's role as a critical pharmaceutical supplier for federal...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for 60 tablets of Multaq 400 mg at a firm fixed price of $21,111.48, with completion scheduled by September 30, 2025. This competitively awarded, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The prime...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for Multaq 400 mg tablets (60-count units) valued at $4,589.64. The contract, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award represents a competitively awarded transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ (dronedarone) 400 mg tablets, quantity 60, valued at $16,743.54 under a firm fixed-price contract with an ultimate completion date of August 15, 2025. This non-set-aside award represents a single delivery order placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The product...
- The Defense Logistics Agency awarded a $1,232.98 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 16, 2025, for the supply of Multaq (dronedarone) 400 mg tablets in a quantity of 60 units. The contract, which is not set-aside, has an ultimate completion date of May 19, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger indefinite delivery vehicle that...
- The Defense Logistics Agency awarded a delivery order valued at $11,496.80 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Multaq 400 mg tablets (60-count packages). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract calls for delivery by August 6, 2025, and performance will occur at the contractor's Conshohocken facility. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Multaq (dronedarone) 400 mg tablets in quantities of 60 units. This firm fixed-price delivery order has a ceiling value of $19,914.33 and an ultimate completion date of September 11, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Multaq is an...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,801.61 for 60-count tablets of MULTAQ 400 mg, a pharmaceutical product used in cardiac arrhythmia management. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizing firm fixed price terms. This delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger pharmaceutical supply...